A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease

M. Boothby*, J. Page, R. Pryor, J. D.C. Ross

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)195-197
    Number of pages3
    JournalInternational Journal of STD and AIDS
    Volume21
    Issue number3
    DOIs
    Publication statusPublished (VoR) - Mar 2010

    Keywords

    • Antimicrobials
    • Moxifloxacin
    • Ofloxacin
    • Pelvic inflammatory disease (PID)
    • Treatment

    Fingerprint

    Dive into the research topics of 'A comparison of treatment outcomes for moxifloxacin versus ofloxacin/metronidazole for first-line treatment of uncomplicated non-gonococcal pelvic inflammatory disease'. Together they form a unique fingerprint.

    Cite this